July 12, 2024Open Access

Hemodialysis patients have signs of a chronic thrombotic burden

Key Points

Key points are not available for this paper at this time.

Abstract

Cardiovascular diseases are the dominant cause of morbidity in hemodialysis (HD) patients. Unless sufficient anticoagulation is used during HD, clotting may appear. The objective was to investigate if levels of fibrin degradation products (D-dimer) were increased before and during HD.

Read Full Paperexternally

اسأل الذكاء الاصطناعي

Bookmark

View Full Paper

Cite This Study

Stegmayr et al. (Fri,) studied this question.

synapsesocial.com/papers/68e60868b6db64358759b6c6 https://doi.org/https://doi.org/10.1186/s12882-024-03654-3

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Anticoagulation in patients with kidney failure on dialysis: factor XI as a therapeutic target2021 · 51 citations
2Citrate Anticoagulation for Postdilutional Online Hemodiafiltration with Calcium-Containing Dialysate and Infusate: Significant Clotting in the Venous Bubble Trap2008 · 30 citations
3Ischaemic memory imaging using metabolic radiopharmaceuticals: overview of clinical settings and ongoing investigations2013 · 32 citations
4[Hardly deep venous thrombosis with normal D-dimer. A sensitive method reduces the need for leg phlebography, according to a retrospective study].2010 · 1 citations
5Mortality due to bleeding, myocardial infarction and stroke in dialysis patients2018 · 31 citations

اسأل الذكاء الاصطناعي

Bookmark

View Full Paper